drugset / Trial / NCT00543959
Efficacy and Tolerability of MK0533 in Patients With Type 2 Diabetes (0533-005)
RandomizedParallel-groupDouble-blindTreatment
Summary
A study to evaluate the effectiveness and tolerability of MK0533 and pioglitazone in patients with type 2 diabetes mellitus.
Timeline
- Start
- 2006-06
- Primary completion
- 2007-08
- Completion
- 2007-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MK0533 | Small molecule | 5 mg | — |
| Subject | MK0533 | Small molecule | 15 mg | — |
| Subject | MK0533 | Small molecule | 30 mg | — |
| Comparator | Pioglitazone | Small molecule | 45 mg | — |